Skip to main content
Literatur
1.
Zurück zum Zitat Pöpperl G, Götz C, Rachinger W, Schnell O, Gildehaus F, Tonn J, et al. Serial O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging 2006;33(7):792–800.PubMedCrossRef Pöpperl G, Götz C, Rachinger W, Schnell O, Gildehaus F, Tonn J, et al. Serial O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma. Eur J Nucl Med Mol Imaging 2006;33(7):792–800.PubMedCrossRef
2.
Zurück zum Zitat Damianovich M, Ziv I, Heyman SN, Rosen S, Shina A, Kidron D, et al. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 2006;33(3):281–91, Mar.PubMedCrossRef Damianovich M, Ziv I, Heyman SN, Rosen S, Shina A, Kidron D, et al. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 2006;33(3):281–91, Mar.PubMedCrossRef
3.
Zurück zum Zitat Carlsson J, Eriksson V, Stenerl B, Lundqvist H. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy. Eur J Nucl Med Mol Imaging 2006;33(10):1185–95, Oct.PubMedCrossRef Carlsson J, Eriksson V, Stenerl B, Lundqvist H. Requirements regarding dose rate and exposure time for killing of tumour cells in beta particle radionuclide therapy. Eur J Nucl Med Mol Imaging 2006;33(10):1185–95, Oct.PubMedCrossRef
4.
Zurück zum Zitat Kwekkeboom DJ, Bakker WH, Kam DL, Teunissen JJ, Kooij PP, deHerder WW, et al. Treatment of patients with gastro-entero-pancreatic tumous with the novel radiolabelled somatostatin analogue (Lu-177-DOTA(0), Tyr(3)) octreotate. Eur J Nucl Med Mol Imaging 2003;30(3):417–22.PubMedCrossRef Kwekkeboom DJ, Bakker WH, Kam DL, Teunissen JJ, Kooij PP, deHerder WW, et al. Treatment of patients with gastro-entero-pancreatic tumous with the novel radiolabelled somatostatin analogue (Lu-177-DOTA(0), Tyr(3)) octreotate. Eur J Nucl Med Mol Imaging 2003;30(3):417–22.PubMedCrossRef
Metadaten
Titel
December editor’s remarks
verfasst von
Ignasi Carrió
Publikationsdatum
01.12.2007
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 12/2007
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-007-0642-8

Weitere Artikel der Ausgabe 12/2007

European Journal of Nuclear Medicine and Molecular Imaging 12/2007 Zur Ausgabe